Gentag, Inc. v. Abbott Laboratories, Inc.
1:23-cv-00310
Overview
Case Number
1:23-cv-00310
Filing Date
2023-01-19
Status
Litigation filed
Court
District Court, N.D. Illinois
Nature of Suit
830 Patent
Parties
Defendant
Plaintiff
Court & Judges
Court
District Court, N.D. Illinois
Presiding Judge
Martha Maria Pacold
Patents Involved
There is a single patent involved in this case.
| Application Number | Patent Number | External Links |
|---|---|---|
| - | US7969307 |
Docket Entries
COMPLAINT filed by Gentag, Inc., Altivera, LLC; Jury Demand. Filing fee $ 402, receipt number AILNDC-20252146. (Attachments: # 1 Exhibit A - U.S. Patent No. 7,969,307, # 2 Exhibit B - 307 Claim Chart)(Hanewicz, Christopher) (Entered: 01/19/2023)
2023-01-19
1
CIVIL Cover Sheet (Hanewicz, Christopher) (Entered: 01/19/2023)
2023-01-19
1
ATTORNEY Appearance for Plaintiffs Altivera, LLC, Gentag, Inc. by Christopher G. Hanewicz (Hanewicz, Christopher) (Entered: 01/19/2023)
2023-01-19
1
ATTORNEY Appearance for Plaintiffs Altivera, LLC, Gentag, Inc. by Michelle M. (Umberger) Kemp ((Umberger) Kemp, Michelle) (Entered: 01/19/2023)
2023-01-19
1
ATTORNEY Appearance for Plaintiffs Altivera, LLC, Gentag, Inc. by Rodger K. Carreyn (Carreyn, Rodger) (Entered: 01/19/2023)
2023-01-19
1
ATTORNEY Appearance for Plaintiffs Altivera, LLC, Gentag, Inc. by Mark Thomas Smith (Smith, Mark) (Entered: 01/19/2023)
2023-01-19
1
ATTORNEY Appearance for Plaintiffs Altivera, LLC, Gentag, Inc. by Gabrielle E Bina (Bina, Gabrielle) (Entered: 01/19/2023)
2023-01-19
1
NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Gentag, Inc. (Hanewicz, Christopher) (Entered: 01/19/2023)
2023-01-19
1
NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Altivera, LLC (Hanewicz, Christopher) (Entered: 01/19/2023)
2023-01-19
1
CASE ASSIGNED to the Honorable Martha M. Pacold. Designated as Magistrate Judge the Honorable Jeffrey T. Gilbert. Case assignment: Random assignment. (khg, )
2023-01-19
1
No Actions
SUMMONS Issued as to Defendants Abbott Diabetes Care, LLC, Abbott Laboratories, Inc. (smb, )
2023-01-19
1
No Actions
CLERK'S NOTICE: Pursuant to Local Rule 73.1(b), a United States Magistrate Judge of this court is available to conduct all proceedings in this civil action. If all parties consent to have the currently assigned United States Magistrate Judge conduct all proceedings in this case, including trial, the entry of final judgment, and all post-trial proceedings, all parties must sign their names on the attached Consent To form. This consent form is eligible for filing only if executed by all parties. The parties can also express their consent to jurisdiction by a magistrate judge in any joint filing, including the Joint Initial Status Report or proposed Case Management Order. (khg, )
2023-01-19
1
No Actions
CERTIFICATE of Service by Plaintiffs Altivera, LLC, Gentag, Inc. regarding complaint 1 (Hanewicz, Christopher) (Entered: 01/27/2023)
2023-01-27
1
MINUTE entry before the Honorable Martha M. Pacold: The parties are directed to file an initial joint status report by 2/24/2023. (Attachments: # 1 Outline for the Initial Joint Status Report) (rao, ) (Entered: 02/02/2023)
2023-02-02
1
First AMENDED complaint by Gentag, Inc., Altivera, LLC against Abbott Laboratories, Abbott Diabetes Care Inc. (Attachments: # 1 Exhibit A - U.S. Patent No. 7,969,307, # 2 Exhibit B - 307 Claim Chart)(Hanewicz, Christopher) (Entered: 02/07/2023)
2023-02-07
1
CERTIFICATE of Service by Plaintiffs Altivera, LLC, Gentag, Inc. regarding amended complaint 12 (Hanewicz, Christopher) (Entered: 02/08/2023)
2023-02-08
1
MINUTE entry before the Honorable Martha M. Pacold: The court will give the parties until 3/3/2023 to file the initial joint status report. (Attachments: # 1 Outline for the Initial Joint Status Report) (rao, ) (Entered: 02/08/2023)
2023-02-08
1
ATTORNEY Appearance for Defendants Abbott Diabetes Care Inc., Abbott Laboratories by Michael A. Morin (Morin, Michael) (Entered: 02/08/2023)
2023-02-08
1
ATTORNEY Appearance for Defendants Abbott Diabetes Care Inc., Abbott Laboratories by Sean M. Berkowitz (Berkowitz, Sean) (Entered: 02/08/2023)
2023-02-08
1
ATTORNEY Appearance for Defendants Abbott Diabetes Care Inc., Abbott Laboratories by Sarah Wenxuan Wang (Wang, Sarah) (Entered: 02/08/2023)
2023-02-08
1
MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number AILNDC-20330627. (Pathmanaban, Giri) (Entered: 02/08/2023)
2023-02-08
1
MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number AILNDC-20330704. (Elliott, Tara) (Entered: 02/08/2023)
2023-02-08
1
MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number AILNDC-20330754. (Akalski, Joseph) (Entered: 02/08/2023)
2023-02-08
1
MOTION by Defendants Abbott Diabetes Care Inc., Abbott Laboratories for extension of time to file answer or otherwise respond to Plaintiffs' Complaint (Unopposed) (Wang, Sarah) (Entered: 02/08/2023)
2023-02-08
1
NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Abbott Laboratories (Wang, Sarah) (Entered: 02/08/2023)
2023-02-08
1
NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Abbott Diabetes Care Inc. (Wang, Sarah) (Entered: 02/08/2023)
2023-02-08
1
MOTION by Defendants Abbott Diabetes Care Inc., Abbott Laboratories for extension of time to file answer or otherwise respond to Plaintiffs' Complaint (Revised) (Unopposed) (Wang, Sarah) (Entered: 02/08/2023)
2023-02-08
1
MINUTE entry before the Honorable Martha M. Pacold: Defendants' revised unopposed motion for extension of time to answer or otherwise respond to Plaintiffs' complaint 24 is granted. Defendants to answer or otherwise plead to the complaint by 4/18/2023. Defendants' original motion for extension of time to answer or otherwise respond to Plaintiffs' complaint 21 is stricken as moot. The parties are given until 4/20/2023 to file the initial joint status report. (Attachments: # 1 Outline for the Initial Joint Status Report) (rao, ) (Entered: 02/09/2023)
2023-02-09
1
ORDER: Giri Pathmanaban's motion for leave to appear pro hac vice on behalf of Abbott Laboratories and Abbott Diabetes Care Inc. 18 is granted. Tara D. Elliott's motion for leave to appear pro hac vice on behalf of Abbott Laboratories and Abbott Diabetes Care Inc. 19 is granted. Joseph C. Akalski's motion for leave to appear pro hac vice on behalf of Abbott Laboratories and Abbott Diabetes Care Inc. 20 is granted. Signed by the Honorable Martha M. Pacold on 2/9/2023. Mailed notice (aee, ) (Entered: 02/09/2023)
2023-02-09
1
MOTION for Leave to Appear Pro Hac Vice Filing fee $ 150, receipt number AILNDC-20388093. (Bell, Gabriel) (Entered: 02/28/2023)
2023-02-28
1
ORDER: Gabriel K. Bell's motion for leave to appear pro hac vice on behalf of defendants Abbott Laboratories and Abbott Diabetes Care Inc. 27 is granted. Signed by the Honorable Martha M. Pacold on 2/28/2023. Mailed notice (aee, ) (Entered: 02/28/2023)
2023-02-28
1
ATTORNEY Appearance for Plaintiffs Altivera, LLC, Gentag, Inc. by Kathleen A. Stetsko (Stetsko, Kathleen) (Entered: 03/24/2023)
2023-03-24
1
WITHDRAWING Mark Thomas Smith as counsel for Plaintiffs Altivera, LLC, Gentag, Inc. and substituting Kathleen A. Stetsko as counsel of record (Stetsko, Kathleen) (Entered: 03/27/2023)
2023-03-27
1
ORDER: Mark Thomas Smith is granted leave to withdraw his appearance as counsel of record and Kathleen A. Stetsko is granted leave to file her appearance on behalf of the defendants. Signed by the Honorable Martha M. Pacold on 3/27/2023. Mailed notice (aee, ) (Entered: 03/27/2023)
2023-03-27
1
MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendants Abbott Diabetes Care Inc., Abbott Laboratories (Berkowitz, Sean) (Entered: 04/18/2023)
2023-04-18
1
MEMORANDUM by Abbott Diabetes Care Inc., Abbott Laboratories in support of Motion to Dismiss for Failure to State a Claim 32 (Berkowitz, Sean) (Entered: 04/18/2023)
2023-04-18
1
DECLARATION of Joseph C. Akalski regarding Motion to Dismiss for Failure to State a Claim 32 (Attachments: # 1 Exhibit 1- Notice of Allowability, U.S. Patent Appl. No. 10/530,901 (which issued as U.S. Patent No. 7,969,307) (Feb. 17, 2011), # 2 Exhibit 2- Response to Office Action, U.S. Patent Appl. No. 10/530,901 (which issued as U.S. Patent No. 7,969,307) (Jan. 25, 2011))(Akalski, Joseph) (Entered: 04/18/2023)
2023-04-18
1
MINUTE entry before the Honorable Martha M. Pacold: Plaintiff's response to Defendants' motion to dismiss 32 is due by 5/10/2023. Defendants' reply is due by 5/24/2023. (rao, ) (Entered: 04/20/2023)
2023-04-20
1
STATUS Report - Initial Joint Status Report and Report of the Parties' Planning Meeting by Altivera, LLC, Gentag, Inc. (Kemp, Michelle) (Entered: 04/20/2023)
2023-04-20
1
MINUTE entry before the Honorable Martha M. Pacold: The court has reviewed the parties' joint status report 36 . Defendants have filed a motion to dismiss 32 and intend to file a motion staying discovery pending the resolution of the motion to dismiss. Plaintiff opposes both motions. This case will be referred to the magistrate judge to hold proceedings related to discovery supervision and scheduling (including the forthcoming motion to stay discovery pending the resolution of the motion to dismiss), to set a deadline to file amended pleadings, to set a dispositive motions schedule, and for settlement. (rao, ) (Entered: 04/21/2023)
2023-04-21
1
Pursuant to Local Rule 72.1, this case is hereby referred to the calendar of Honorable Jeffrey T. Gilbert for the purpose of holding proceedings related to: discovery supervision and scheduling (including the forthcoming motion to stay discovery pending the resolution of the motion to dismiss), to set a deadline to file amended pleadings, to set a dispositive motions schedule, and for settlement. (rao, ) (Entered: 04/21/2023)
2023-04-21
1
MOTION by Defendants Abbott Diabetes Care Inc., Abbott Laboratories to stay Discovery Pending Resolution of their Motion to Dismiss Under Rule 12(b)(6) (Berkowitz, Sean) (Entered: 04/24/2023)
2023-04-24
1
MEMORANDUM by Abbott Diabetes Care Inc., Abbott Laboratories in support of motion to stay 39 Discovery Pending Resolution of their Motion to Dismiss Under Rule 12(b)(6) (Attachments: # 1 Exhibit 1)(Berkowitz, Sean) (Entered: 04/24/2023)
2023-04-24
1
MINUTE entry before the Honorable Jeffrey T. Gilbert: This case has been referred to Magistrate Judge Gilbert for the purposes of holding proceedings related to discovery supervision and scheduling, including Defendants' Motion to Stay Discovery 39, to set a deadline to file amended pleadings, to set a dispositive motion schedule, and for settlement. The Court sets the following briefing schedule on Defendants' Motion to Stay Discovery Pending Resolution of their Motion to Dismiss Under Rule 12(b)(6) 39 : Response due by 5/10/23. Reply due by 5/22/23. Mailed notice (ber, ) (Entered: 04/26/2023)
2023-04-26
1
MEMORANDUM by Altivera, LLC, Gentag, Inc. in Opposition to Motion to Dismiss for Failure to State a Claim 32 (Hanewicz, Christopher) (Entered: 05/10/2023)
2023-05-10
1
MEMORANDUM by Altivera, LLC, Gentag, Inc. in Opposition to motion to stay 39 (Attachments: # 1 Exhibit 1- Bookmarked PDF of Cited Cases (Westlaw) Only on Electronic Databases)(Hanewicz, Christopher) (Entered: 05/10/2023)
2023-05-10
1
MOTION by Defendants Abbott Diabetes Care Inc., Abbott Laboratories to Amend Joint Proposed Case Schedule (Unopposed) Presented before Presiding Judge (Pathmanaban, Giri) (Entered: 05/11/2023)
2023-05-11
1
MINUTE entry before the Honorable Jeffrey T. Gilbert: The parties' Unopposed Motion to Amend Joint Proposed Case Schedule 44 is granted. Mailed notice (ber, ) (Entered: 05/15/2023)
2023-05-15
1
CASE MANAGEMENT ORDER NO. 1. Mailed notice (ber, ) (Entered: 05/15/2023)
2023-05-15
1
REPLY by Abbott Diabetes Care Inc., Abbott Laboratories to MOTION by Defendants Abbott Diabetes Care Inc., Abbott Laboratories to stay Discovery Pending Resolution of their Motion to Dismiss Under Rule 12(b)(6) 39 (Attachments: # 1 Exhibit 2, # 2 Index of Cited Cases)(Berkowitz, Sean) (Entered: 05/22/2023)
2023-05-22
1
REPLY by Defendants Abbott Diabetes Care Inc., Abbott Laboratories to Motion to Dismiss for Failure to State a Claim 32 (Berkowitz, Sean) (Entered: 05/24/2023)
2023-05-24
1
MINUTE entry before the Honorable Jeffrey T. Gilbert: A hearing on Defendants' Motion to Stay Discovery 39 is set for 6/7/23 at 10:00 a.m. via video conference. The call-in number is 650-479-3207 and the Access code: 180 946 2499. Counsel of record will receive an email invitation prior to the start of the video hearing with instructions to join the video conference. Persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in sanctions, including removal of court issued media credentials, restricted entry to future hearings, denial of entry to future hearings, or any other sanctions deemed necessary by the Court. Mailed notice (ber, ) (Entered: 06/01/2023)
2023-06-01
1
MINUTE entry before the Honorable Jeffrey T. Gilbert: Motion hearing held on 6/7/23. For the reasons stated on the record, Defendants' Motion to Stay Discovery 39 is denied without prejudice. The parties shall file an updated status report by 9/8/23 that includes the following information and anything else relevant to case management the parties wish to include: (1) a description of where the parties are in written discovery, whether there are any disputes, and if so, whether the parties have embarked on or completed the Local Rule 37.2 process with respect to any such disputes, and the parties' proposed next steps in that respect; (2) to the extent possible, the names of the fact witnesses that either side then intends to depose before the close of discovery; and (3) any proposed or confirmed dates for those depositions the parties have calendared. Mailed notice (ber, ) (Entered: 06/08/2023)
2023-06-08
1
MOTION by Defendants Abbott Diabetes Care Inc., Abbott Laboratories to Amend Case Management Order No. 1 (Joint) Presented before Magistrate Judge (Berkowitz, Sean) (Entered: 06/12/2023)
2023-06-12
1
MINUTE entry before the Honorable Jeffrey T. Gilbert: The parties' Joint Motion to Amend Case Management Order No. 1 51 is granted. The parties shall submit a draft Case Management Order No. 2 to the Court's proposed order email address at Proposed_Order_Gilbert@ilnd.uscourts.gov. Mailed notice (ber, ) (Entered: 06/14/2023)
2023-06-14
1
CASE MANAGEMENT ORDER NO. 2. Signed by the Honorable Jeffrey T. Gilbert on 6/16/2023. Mailed notice(ber, ) (Entered: 06/16/2023)
2023-06-16
1
NOTICE by All Plaintiffs re MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendants Abbott Diabetes Care Inc., Abbott Laboratories 32 Notice of Supplemental Authority (Attachments: # 1 Exhibit A: Buffalo Patents opinion.)(Kemp, Michelle) (Entered: 07/26/2023)
2023-07-26
1
NOTICE by Abbott Diabetes Care Inc., Abbott Laboratories re MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendants Abbott Diabetes Care Inc., Abbott Laboratories 32 Notice of Supplemental Authority (Attachments: # 1 Exhibit A - Trinity Info Media, LLC v. Covalent, Inc.)(Berkowitz, Sean) (Entered: 07/26/2023)
2023-07-26
1
MINUTE entry before the Honorable Martha M. Pacold: The court has received the parties' notices of supplemental authority ( 54, 55 ). (rao, ) (Entered: 07/27/2023)
2023-07-27
1
SUPPLEMENT to motion to appear pro hac Vice, [dkt.27] (Attachments: # 1 Amended Motion to Appear Pro Hac Vice)(Bell, Gabriel) (Entered: 08/07/2023)
2023-08-07
1
MINUTE entry before the Honorable Martha M. Pacold: The court has received defendant's supplement to the motion to appear pro hac vice 57 . The court previously granted defendant's motion 28 . No further action is required. (rao, ) (Entered: 08/08/2023)
2023-08-08
1
ATTORNEY Appearance for Plaintiffs Altivera, LLC, Gentag, Inc. by David R. Pekarek Krohn (Pekarek Krohn, David) (Entered: 08/09/2023)
2023-08-09
1
MOTION by Defendants Abbott Diabetes Care Inc., Abbott Laboratories for protective order /Joint Motion for Entry of Stipulated Protective Order Presented before Magistrate Judge (Pathmanaban, Giri) (Entered: 08/10/2023)
2023-08-10
1
MINUTE entry before the Honorable Jeffrey T. Gilbert: Joint Motion for Entry of Stipulated Protective Order 60 is granted. Mailed notice (ber, ) (Entered: 08/14/2023)
2023-08-14
1
STIPULATED PROTECTIVE Order. Signed by the Honorable Jeffrey T. Gilbert on 8/14/2023. Mailed notice(ber, ) (Entered: 08/14/2023)
2023-08-14
1
STATUS Report Regarding Discovery, Submitted Jointly by the Parties by Altivera, LLC, Gentag, Inc. Presented before Magistrate Judge (Kemp, Michelle) (Entered: 09/08/2023)
2023-09-08
1
SUPPLEMENT to memorandum in opposition to motion 42 Notice of Supplemental Authority (Attachments: # 1 Exhibit A)(Kemp, Michelle) (Entered: 09/20/2023)
2023-09-20
1
TRANSCRIPT OF PROCEEDINGS held on 06/07/23 before the Honorable Jeffrey T. Gilbert. Order Number: 46804. Court Reporter Contact Information: Patrick Mullen, (312) 435-5565, patrick_mullen@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 10/11/2023. Redacted Transcript Deadline set for 10/23/2023. Release of Transcript Restriction set for 12/19/2023. (Mullen, Patrick) (Entered: 09/20/2023)
2023-09-20
1
MINUTE entry before the Honorable Jeffrey T. Gilbert: The Court reviewed the parties' Joint Status Report 63 . The parties shall file an updated status report by 10/23/23 that contains the same categories of information as their last status report. Mailed notice (ber, ) (Entered: 09/29/2023)
2023-09-29
1
STATUS Report - Joint by Altivera, LLC, Gentag, Inc. Presented before Magistrate Judge (Kemp, Michelle) (Entered: 10/23/2023)
2023-10-23
1
MOTION by Defendants Abbott Diabetes Care Inc., Abbott Laboratories to Amend Case Management Order No. 2 (Joint) Presented before Magistrate Judge (Pathmanaban, Giri) (Entered: 11/08/2023)
2023-11-08
1
MINUTE entry before the Honorable Jeffrey T. Gilbert: Joint Motion to Amend Case Management Order No. 2 68 is granted. Enter Case Management Order No. 3. Mailed notice (ber, ) (Entered: 11/14/2023)
2023-11-14
1
CASE MANAGEMENT ORDER NO. 3. Signed by the Honorable Jeffrey T. Gilbert on 11/14/2023. Mailed notice(ber, ) (Entered: 11/14/2023)
2023-11-14
1
MINUTE entry before the Honorable Jeffrey T. Gilbert: The Court reviewed the parties' Joint Status Report 67 . The parties shall file an updated status report by 1/15/24. Mailed notice (ber, ) (Entered: 11/17/2023)
2023-11-17
1
ANNUAL REMINDER: Pursuant to Local Rule 3.2 (Notification of Affiliates), any nongovernmental party, other than an individual or sole proprietorship, must file a statement identifying all its affiliates known to the party after diligent review or, if the party has identified no affiliates, then a statement reflecting that fact must be filed. An affiliate is defined as follows: any entity or individual owning, directly or indirectly (through ownership of one or more other entities), 5% or more of a party. The statement is to be electronically filed as a PDF in conjunction with entering the affiliates in CM/ECF as prompted. As a reminder to counsel, parties must supplement their statements of affiliates within thirty (30) days of any change in the information previously reported. This minute order is being issued to all counsel of record to remind counsel of their obligation to provide updated information as to additional affiliates if such updating is necessary. If counsel has any questions regarding this process, this LINK will provide additional information. Signed by the Executive Committee on 12/28/2023: Mailed notice. (tg, ) (Entered: 12/29/2023)
2023-12-28
1
STATUS Report Joint by Altivera, LLC, Gentag, Inc. Presented before Magistrate Judge (Kemp, Michelle) (Entered: 01/16/2024)
2024-01-16
1
MOTION by Defendants Abbott Diabetes Care Inc., Abbott Laboratories to stay -Joint Motion for Partial Stay of Discovery Presented before Magistrate Judge (Pathmanaban, Giri) (Entered: 01/30/2024)
2024-01-30
1
MINUTE entry before the Honorable Jeffrey T. Gilbert: Joint Motion for Partial Stay of Discovery 74 is granted. For the reasons outlined by the parties, the Court agrees there is good cause to stay discovery until the entry of a claim construction order except for the exchange of responses to final contentions (due by 2/13/24) and Defendant Abbott's production in response to Plaintiff Gentag's requests for the production of email from four custodians as set forth in the Motion 74 at 2. Discovery will reopen for a period of 90 days upon entry of a claim construction order. Mailed notice (ber, ) (Entered: 02/02/2024)
2024-02-02
1
MINUTE entry before the Honorable Jeffrey T. Gilbert: The Court reviewed the parties' Joint Status Report 73 . The parties shall file an updated status report by 3/29/24. Mailed notice (ber, ) (Entered: 02/02/2024)
2024-02-02
1
STATUS Report JOINT by Altivera, LLC, Gentag, Inc. Presented before Magistrate Judge (Hanewicz, Christopher) (Entered: 03/29/2024)
2024-03-29
1
MINUTE entry before the Honorable Jeffrey T. Gilbert: The Court reviewed the parties' Joint Status Report 77 . The parties shall file an updated status report by 5/28/24 that addresses the same topics as their last status report and also identifies any depositions that have been taken since their last status report. Mailed notice (ber, ) (Entered: 04/03/2024)
2024-04-03
1
Defendants' Opening Claim Construction Brief by Abbott Diabetes Care Inc., Abbott Laboratories (Attachments: # 1 Exhibit A)(Pathmanaban, Giri) (Entered: 04/05/2024)
2024-04-05
1
APPENDIX Pursuant to LPR 4.2(b) (Joint) (Pathmanaban, Giri) (Entered: 04/05/2024)
2024-04-05
1
NOTICE by Abbott Diabetes Care Inc., Abbott Laboratories re MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM by Defendants Abbott Diabetes Care Inc., Abbott Laboratories 32 Notice of Supplemental Authority (Attachments: # 1 Exhibit A - AI Visualize, Inc. v. Nuance Communications, Inc.)(Pathmanaban, Giri) (Entered: 04/05/2024)
2024-04-05
1
RESPONSE by Plaintiffs Altivera, LLC, Gentag, Inc. to other 79 Plaintiffs' Responsive Claim Construction Brief (Hanewicz, Christopher) (Entered: 05/03/2024)
2024-05-03
1
DECLARATION of Christopher G. Hanewicz regarding Response 82 in Support of Plaintiffs' Responsive Claim Construction Brief (Attachments: # 1 Exhibit 1 American Science Dicitonary, # 2 Exhibit 2 Wikipedia Page)(Hanewicz, Christopher) (Entered: 05/03/2024)
2024-05-03
1
MOTION by Defendants Abbott Diabetes Care Inc., Abbott Laboratories to Amend Case Management Order No. 3 (Unopposed) Presented before Magistrate Judge (Pathmanaban, Giri) (Entered: 05/09/2024)
2024-05-09
1
MINUTE entry before the Honorable Jeffrey T. Gilbert: Unopposed Motion to Amend Case Management Order No. 3 84 is granted. Mailed notice (ber, ) (Entered: 05/13/2024)
2024-05-13
1
CASE MANAGEMENT ORDER NO. 4. Signed by the Honorable Jeffrey T. Gilbert on 5/13/2024. Mailed notice(ber, ) (Entered: 05/13/2024)
2024-05-13
1
REPLY by Defendants Abbott Diabetes Care Inc., Abbott Laboratories to other 79 Defendants' Opening Claim Construction Brief (Attachments: # 1 Exhibit A)(Pathmanaban, Giri) (Entered: 05/24/2024)
2024-05-24
1
STATUS Report - Joint by Altivera, LLC, Gentag, Inc. Presented before Magistrate Judge (Hanewicz, Christopher) (Entered: 05/28/2024)
2024-05-28
1
Joint Claim Construction Chart and Status Report by Abbott Diabetes Care Inc., Abbott Laboratories (Pathmanaban, Giri) (Entered: 05/30/2024)
2024-05-30
1
MINUTE entry before the Honorable Jeffrey T. Gilbert: The Court reviewed the parties' Joint Status Report 88 . The parties shall file an updated status report by 7/30/24. Mailed notice (ber, ) (Entered: 05/31/2024)
2024-05-31
1
STATUS Report - Joint by Altivera, LLC, Gentag, Inc. Presented before Magistrate Judge (Hanewicz, Christopher) (Entered: 07/30/2024)
2024-07-30
1
MINUTE entry before the Honorable Jeffrey T. Gilbert: The Court reviewed parties' Joint Status Report 91 . The parties shall file an updated joint status report by 9/16/24. Mailed notice (ber, ) (Entered: 08/07/2024)
2024-08-07
1
STATUS Report - Joint by Altivera, LLC, Gentag, Inc. Presented before Magistrate Judge (Hanewicz, Christopher) (Entered: 09/16/2024)
2024-09-16
1
MINUTE entry before the Honorable Martha M. Pacold: Telephone status hearing set for 11/6/2024 at 9:00 a.m. Dial toll-free call-in number: 888-684-8852; followed by the conference access code: 9482028#. Persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting of court proceedings. Violation of these prohibitions may result in sanctions deemed necessary by the court. (rao, ) (Entered: 10/24/2024)
2024-10-24
1
MINUTE entry before the Honorable Jeffrey T. Gilbert: The Court reviewed the parties' Joint Status Report 93 . The Court will set another date for an updated status report or schedule a status hearing in a future order. Mailed notice (ber, ) (Entered: 10/31/2024)
2024-10-31
1
MINUTE entry before the Honorable Martha M. Pacold: Telephone status hearing held on 11/6/2024. Defendants' motion to stay this lawsuit pending a final decision in IPR2024-00425 is due by 11/18/2024. Plaintiff's response is due by 12/4/2024. Defendants' reply, if any, is due by 12/11/2024. All briefs relating to the motion to stay are limited to 10 pages. (rao, ) (Entered: 11/06/2024)
2024-11-06
1
MOTION by Defendants Abbott Laboratories, Abbott Diabetes Care Inc. to stay Pending Inter Partes Review (Joint) Presented before District Judge (Pathmanaban, Giri) (Entered: 11/14/2024)
2024-11-14
1
TRANSCRIPT OF PROCEEDINGS held on 11/6/24 before the Honorable Martha M. Pacold. Order Number: 50312. Court Reporter Contact Information: Kathleen_Fennell@ilnd.uscourts.gov. IMPORTANT: The transcript may be viewed at the court's public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through the Court Reporter/Transcriber or PACER. For further information on the redaction process, see the Court's web site at www.ilnd.uscourts.gov under Quick Links select Policy Regarding the Availability of Transcripts of Court Proceedings. Redaction Request due 12/9/2024. Redacted Transcript Deadline set for 12/19/2024. Release of Transcript Restriction set for 2/17/2025. (Fennell, Kathleen) (Entered: 11/18/2024)
2024-11-18
1
MINUTE entry before the Honorable Martha M. Pacold: Pursuant to the parties' joint motion to stay the case pending inter partes review, 97, this case is stayed pending a final decision in IPR2024-00425. See Ethicon, Inc. v. Quigg, 849 F.2d 1422, 142627 (Fed. Cir. 1988) ("Courts have inherent power to manage their dockets and stay proceedings, including the authority to order a stay pending conclusion of a PTO reexamination." (citing Landis v. N. Am. Co., 299 U.S. 248, 254 (1936))). Given the stay, for docket management purposes only, defendants' motion to dismiss, 32, is denied without reaching the merits and without prejudice to renewal at a later date. Mailed notice. (kp, ) (Entered: 12/09/2024)
2024-12-09
1
MINUTE entry before the Honorable Jeffrey T. Gilbert: In light of the District Judge's order 99, the referral in this matter is terminated and this case is returned to the District Judge. Referral terminated. Mailed notice (ber, ) (Entered: 12/10/2024)
2024-12-10
1
ANNUAL REMINDER: Pursuant to Local Rule 3.2 (Notification of Affiliates), any nongovernmental party, other than an individual or sole proprietorship, must file a statement identifying all its affiliates known to the party after diligent review or, if the party has identified no affiliates, then a statement reflecting that fact must be filed. An affiliate is defined as follows: any entity or individual owning, directly or indirectly (through ownership of one or more other entities), 5% or more of a party. The statement is to be electronically filed as a PDF in conjunction with entering the affiliates in CM/ECF as prompted. As a reminder to counsel, parties must supplement their statements of affiliates within thirty (30) days of any change in the information previously reported. This minute order is being issued to all counsel of record to remind counsel of their obligation to provide updated information as to additional affiliates if such updating is necessary. If counsel has any questions regarding this process, this LINK will provide additional information. Signed by the Honorable Virginia M. Kendall on 12/27/2024: Mailed notice. (tg, ) (Entered: 12/28/2024)
2024-12-27
1
MOTION by Attorney Giri Pathmanaban to withdraw as attorney for Abbott Diabetes Care Inc., Abbott Laboratories. No party information provided (Pathmanaban, Giri) (Entered: 03/28/2025)
2025-03-28
1
ORDER: Defendants' motion to withdraw the appearance of Giri Pathmanaban as counsel of record 102 is granted. Giri Pathmanaban is terminated. Signed by the Honorable Martha M. Pacold on 3/28/2025. Mailed notice (aee, ) (Entered: 03/28/2025)
2025-03-28
1
MOTION by Attorney Joseph C. Akalski to withdraw as attorney for Abbott Diabetes Care Inc., Abbott Laboratories. No party information provided (Akalski, Joseph) (Entered: 04/17/2025)
2025-04-17
1
ORDER: Defendants' motion to withdraw the appearance of attorney Joseph C. Akalski as counsel of record 104 is granted. Joseph C. Akalski is terminated. Signed by the Honorable Martha M. Pacold on 4/18/2025. Mailed notice (aee, ) (Entered: 04/18/2025)
2025-04-18
1
MOTION by Attorney Sarah Wang to withdraw as attorney for Abbott Diabetes Care Inc., Abbott Laboratories. No party information provided (Wang, Sarah) (Entered: 05/13/2025)
2025-05-13
1
ORDER: Defendants' motion to withdraw the appearance of Sarah Wang as counsel of record, 106, is granted. Sarah Wang is terminated. Signed by the Honorable Martha M. Pacold on 5/13/2025. Mailed notice (aee, ) (Entered: 05/13/2025)
2025-05-13
1
MOTION by Defendants Abbott Diabetes Care Inc., Abbott Laboratories to continue Stay and Notice of PTAB Unpatentability of U.S. Patent No. 7,969,307 (Joint) (Morin, Michael) (Entered: 07/25/2025)
2025-07-25
1
MINUTE entry before the Honorable Martha M. Pacold: The parties' joint motion for continued stay, 108, is granted. The parties shall file a joint status report by 12/16/2025, addressing the status of PTAB proceedings and/or appeal. The case will remain administratively closed while the stay is in place, but any party may move to lift the stay and reopen the case at any time. (rao, ) (Entered: 07/28/2025)
2025-07-28
1
STATUS Report - Joint by Altivera, LLC, Gentag, Inc. (Pekarek Krohn, David) (Entered: 12/16/2025)
2025-12-16
1
MINUTE entry before the Honorable Martha M. Pacold: The court has reviewed the parties' joint status report, 110, which reports that plaintiffs filed an appeal with the United States Court of Appeals for the Federal Circuit. The case remains stayed. By 4/16/2026, the parties are directed to file an updated joint status report addressing the status of the CAFC appeal. Mailed notice. (lxk, ) (Entered: 12/18/2025)
2025-12-18
1
Local Rule 3.2 Annual Reminder Order
2026-01-05
1